1.73
                                            Schlusskurs vom Vortag:
              $1.75
            Offen:
              $1.76
            24-Stunden-Volumen:
                130.89K
            Relative Volume:
              0.50
            Marktkapitalisierung:
                $135.58M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              -
            KGV:
              -
            EPS:
                -
            Netto-Cashflow:
                -
            1W Leistung:
              +3.59%
            1M Leistung:
              -14.78%
            6M Leistung:
                +93.51%
            1J Leistung:
              +42.98%
            Citius Oncology Inc Stock (CTOR) Company Profile
Firmenname
                  
                      Citius Oncology Inc
                    
                Sektor
                  Telefon
                  
                      (908) 967-6677
                    
                Adresse
                  
                      11 COMMERCE DRIVE, CRANFORD
                    
                Vergleichen Sie CTOR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
|   
                          
                                CTOR
                            
                             Citius Oncology Inc | 1.73 | 146.15M | 0 | 0 | 0 | 0.00 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 144.10 | 63.79B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.23 | 43.49B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.18 | 40.30B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.03 | 23.21B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 453.53 | 20.59B | 3.08B | 1.24B | 1.07B | 25.61 | 
Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-09-23 | Hochstufung | Maxim Group | Hold → Buy | 
| 2024-11-27 | Eingeleitet | Maxim Group | Buy | 
Citius Oncology Inc Aktie (CTOR) Neueste Nachrichten
Regression analysis insights on Citius Oncology Inc. performanceJuly 2025 Recap & Expert Curated Trade Ideas - newser.com
News impact scoring models applied to Citius Oncology Inc.2025 Short Interest & Reliable Price Action Trade Plans - newser.com
Why retail investors favor Citius Oncology Inc. stockGap Up & Weekly Setup with High ROI Potential - newser.com
How Citius Oncology Inc. stock benefits from strong dollarJuly 2025 Momentum & Entry and Exit Point Strategies - newser.com
Real time social sentiment graph for Citius Oncology Inc.2025 Market Trends & AI Forecasted Entry and Exit Points - newser.com
Building trade automation scripts for Citius Oncology Inc.2025 Price Momentum & Weekly Setup with ROI Potential - newser.com
Published on: 2025-10-29 00:05:52 - newser.com
Predicting Citius Oncology Inc. trend using moving averagesMarket Activity Summary & Fast Gain Swing Alerts - newser.com
Published on: 2025-10-28 05:08:21 - newser.com
What data driven models say about Citius Oncology Inc.’s futureWeekly Market Report & Safe Capital Preservation Plans - newser.com
Is Citius Oncology Inc. stock a buy on dipsM&A Rumor & Weekly High Momentum Picks - Fundação Cultural do Pará
What high frequency data says about Citius Oncology Inc.Trend Reversal & Entry and Exit Point Strategies - newser.com
Is Citius Oncology Inc. stock attractive for long term wealth buildingAnalyst Upgrade & Community Verified Watchlist Alerts - newser.com
Citius Oncology Stockholders Approve Share Increase - TipRanks
What analysts say about Citius Oncology Inc stockVWAP Trading Strategies & Investment Timing Techniques - earlytimes.in
Finanzdaten der Citius Oncology Inc-Aktie (CTOR)
        Es liegen keine Finanzdaten für Citius Oncology Inc (CTOR) vor. Überprüfen Sie andere Aktien für weitere Informationen.
    
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App